(Q43035022)

English

Real-time quantification of human telomerase reverse transcriptase mRNA in liver tissues from patients with hepatocellular cancer and chronic viral hepatitis

scientific article published in January 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Real-time quantification of human telomerase reverse transcriptase mRNA in liver tissues from patients with hepatocellular cancer and chronic viral hepatitis (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

hepatocellular carcinoma

1 reference

based on heuristic

inferred from title

author name string

Satra M

1

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Gatselis N

2

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Iliopoulos D

3

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Zacharoulis D

4

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Dalekos GN

5

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Tsezou A

6

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

publication date

1 January 2007

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Journal of Viral Hepatitis

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

14

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

41-47

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Human telomerase and its regulation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00769.X

21 January 2018

Telomerase catalytic subunit homologs from fission yeast and human

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00769.X

21 January 2018

Role of telomerase in cellular proliferation and cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00769.X

21 January 2018

Telomerase in cancer and aging

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00769.X

21 January 2018

On the road to immortality: hTERT upregulation in cancer cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00769.X

21 January 2018

Telomerase as tumor marker

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00769.X

21 January 2018

Telomeres and telomerase: new targets for the treatment of liver cirrhosis and hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00769.X

21 January 2018

Significance of telomerase activity in the diagnosis of small differentiated hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00769.X

21 January 2018

Precancerous hepatic nodules had significant levels of telomerase activity determined by sensitive quantitation using a hybridization protection assay

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00769.X

21 January 2018

Telomerase activation by hTRT in human normal fibroblasts and hepatocellular carcinomas

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00769.X

21 January 2018

Expression of telomerase-associated protein 1 and telomerase reverse transcriptase in hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00769.X

21 January 2018

Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00769.X

21 January 2018

Idiopathic dilated cardiomyopathy: lack of association with hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00769.X

21 January 2018

EASL International Consensus Conference on Hepatitis B. 13-14 September, 2002: Geneva, Switzerland. Consensus statement (short version).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00769.X

21 January 2018

Telomerase and c-myc expression in hepatocellular carcinomas

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00769.X

21 January 2018

Telomerase is strongly activated in hepatocellular carcinoma but not in chronic hepatitis and cirrhosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00769.X

21 January 2018

Cellular distribution of telomerase reverse transcriptase in human hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00769.X

21 January 2018

Pathogenesis of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00769.X

21 January 2018

Telomerase activity and telomere length in human hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00769.X

21 January 2018

Identifiers

10.1111/J.1365-2893.2006.00769.X

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43035022&oldid=1978265475"